REVVITY, INC Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
REVVITY, INC (RVTY) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $300.00 thousand for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-02-24
- REVVITY, INC unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $300.00K.
- REVVITY, INC unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was -$1.20M.
- REVVITY, INC unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was -$1.10M, a 320.00% decline from fiscal 2023.
- REVVITY, INC unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $500.00K, a 72.22% decline from fiscal 2022.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month as first filed |
|---|---|---|
| 2025-12-28 | $300.00K 10-K · filed 2026-02-24 | |
| 2024-12-29 | -$1.20M 10-K · filed 2026-02-24 | $1.20M 10-K · filed 2025-02-25 |
| 2023-12-31 | -$1.10M 10-K · filed 2026-02-24 | |
| 2023-01-01 | $500.00K 10-K · filed 2025-02-25 | -$500.00K 10-K · filed 2023-03-01 |
| 2022-01-02 | $1.80M 10-K · filed 2024-02-27 | |
| 2021-01-03 | $1.80M 10-K · filed 2023-03-01 | $4.70M 10-K · filed 2021-03-02 |
| 2019-12-29 | $1.60M 10-K · filed 2022-03-03 | |
| 2018-12-30 | $400.00K 10-K · filed 2021-03-02 | |
| 2017-12-31 | -$300.00K 10-K · filed 2020-02-25 | |
| 2017-01-01 | -$100.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |